Suppr超能文献

FAT10与MAD2结合的破坏会抑制肿瘤进展。

Disruption of FAT10-MAD2 binding inhibits tumor progression.

作者信息

Theng Steven Setiawan, Wang Wei, Mah Way-Champ, Chan Cheryl, Zhuo Jingli, Gao Yun, Qin Haina, Lim Liangzhong, Chong Samuel S, Song Jianxing, Lee Caroline G

机构信息

Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore; National University of Singapore Graduate School of Integrative Sciences and Engineering, National University of Singapore, Singapore 119077, Singapore;

Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore 119077, Singapore;

出版信息

Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):E5282-91. doi: 10.1073/pnas.1403383111. Epub 2014 Nov 24.

Abstract

FAT10 (HLA-F-adjacent transcript 10) is a ubiquitin-like modifier that is commonly overexpressed in various tumors. It was found to play a role in mitotic regulation through its interaction with mitotic arrest-deficient 2 (MAD2). Overexpression of FAT10 promotes tumor growth and malignancy. Here, we identified the MAD2-binding interface of FAT10 to be located on its first ubiquitin-like domain whose NMR structure thus was determined. We further proceeded to demonstrate that disruption of the FAT10-MAD2 interaction through mutation of specific MAD2-binding residues did not interfere with the interaction of FAT10 with its other known interacting partners. Significantly, ablation of the FAT10-MAD2 interaction dramatically limited the promalignant capacity of FAT10, including promoting tumor growth in vivo and inducing aneuploidy, proliferation, migration, invasion, and resistance to apoptosis in vitro. Our results strongly suggest that the interaction of FAT10 with MAD2 is a key mechanism underlying the promalignant property of FAT10 and offer prospects for the development of anticancer strategies.

摘要

FAT10(HLA - F相邻转录本10)是一种类泛素修饰因子,在多种肿瘤中通常呈过表达状态。研究发现它通过与有丝分裂阻滞缺陷蛋白2(MAD2)相互作用,在有丝分裂调控中发挥作用。FAT10的过表达促进肿瘤生长和恶性进展。在此,我们确定FAT10与MAD2的结合界面位于其首个类泛素结构域,进而测定了该结构域的核磁共振结构。我们进一步证明,通过突变特定的MAD2结合残基破坏FAT10与MAD2的相互作用,并不影响FAT10与其其他已知相互作用伙伴的相互作用。值得注意的是,消除FAT10与MAD2的相互作用极大地限制了FAT10的促恶性能力,包括在体内促进肿瘤生长以及在体外诱导非整倍体形成、增殖、迁移、侵袭和抗凋亡。我们的结果强烈表明,FAT10与MAD2的相互作用是FAT10促恶性特性的关键机制,并为抗癌策略的开发提供了前景。

相似文献

1
Disruption of FAT10-MAD2 binding inhibits tumor progression.
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):E5282-91. doi: 10.1073/pnas.1403383111. Epub 2014 Nov 24.
2
FAT10 plays a role in the regulation of chromosomal stability.
J Biol Chem. 2006 Apr 21;281(16):11413-21. doi: 10.1074/jbc.M507218200. Epub 2006 Feb 22.
3
FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells.
Carcinogenesis. 2014 Apr;35(4):923-34. doi: 10.1093/carcin/bgt407. Epub 2013 Dec 9.
4
FAT10 mediates the effect of TNF-α in inducing chromosomal instability.
J Cell Sci. 2011 Nov 1;124(Pt 21):3665-75. doi: 10.1242/jcs.087403. Epub 2011 Oct 24.
5
The ubiquitin-like modifier FAT10 in cancer development.
Int J Biochem Cell Biol. 2016 Oct;79:451-461. doi: 10.1016/j.biocel.2016.07.001. Epub 2016 Jul 5.
6
Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin.
Oncotarget. 2016 Dec 6;7(49):81463-81473. doi: 10.18632/oncotarget.12976.
7
Recombinant adenovirus encoding FAT10 small interfering RNA inhibits HCC growth in vitro and in vivo.
Exp Mol Pathol. 2014 Apr;96(2):207-11. doi: 10.1016/j.yexmp.2014.01.001. Epub 2014 Jan 14.
9
Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
Cancer Res. 2014 Sep 15;74(18):5287-300. doi: 10.1158/0008-5472.CAN-14-0284. Epub 2014 Jul 23.
10
Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon.
Oncogene. 2008 Oct 9;27(46):6068-74. doi: 10.1038/onc.2008.201. Epub 2008 Jun 23.

引用本文的文献

1
NUB1 traps unfolded FAT10 for ubiquitin-independent degradation by the 26S proteasome.
Nat Struct Mol Biol. 2025 Apr 11. doi: 10.1038/s41594-025-01527-3.
5
Nub1 traps unfolded FAT10 for ubiquitin-independent degradation by the 26S proteasome.
bioRxiv. 2024 Jun 12:2024.06.12.598715. doi: 10.1101/2024.06.12.598715.
6
Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance.
Sci China Life Sci. 2024 Jul;67(7):1413-1426. doi: 10.1007/s11427-023-2460-0. Epub 2024 Apr 1.
7
UBDP1 pseudogene and UBD network competitively bind miR‑6072 to promote glioma progression.
Int J Oncol. 2024 Mar;64(3). doi: 10.3892/ijo.2024.5617. Epub 2024 Jan 26.
8
Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditions.
Life Sci Alliance. 2023 Aug 21;6(11). doi: 10.26508/lsa.202301985. Print 2023 Nov.
9
FAT10 Induces cancer cell migration by stabilizing phosphorylated ABI3/NESH.
Anim Cells Syst (Seoul). 2023 Mar 11;27(1):53-60. doi: 10.1080/19768354.2023.2186486. eCollection 2023.
10
Ubiquitin D promotes the progression of rheumatoid arthritis via activation of the p38 MAPK pathway.
Mol Med Rep. 2023 Feb;27(2). doi: 10.3892/mmr.2023.12940. Epub 2023 Jan 20.

本文引用的文献

1
FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells.
Carcinogenesis. 2014 Apr;35(4):923-34. doi: 10.1093/carcin/bgt407. Epub 2013 Dec 9.
2
Using chemical shift perturbation to characterise ligand binding.
Prog Nucl Magn Reson Spectrosc. 2013 Aug;73:1-16. doi: 10.1016/j.pnmrs.2013.02.001. Epub 2013 Mar 21.
4
Profiling of ubiquitin-like modifications reveals features of mitotic control.
Cell. 2013 Feb 28;152(5):1160-72. doi: 10.1016/j.cell.2013.02.007.
5
The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation.
J Cell Sci. 2012 Oct 1;125(Pt 19):4576-85. doi: 10.1242/jcs.107789. Epub 2012 Jul 13.
8
The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation.
Cell Mol Life Sci. 2012 Jul;69(14):2443-54. doi: 10.1007/s00018-012-0933-5. Epub 2012 Feb 19.
9
FAT10 mediates the effect of TNF-α in inducing chromosomal instability.
J Cell Sci. 2011 Nov 1;124(Pt 21):3665-75. doi: 10.1242/jcs.087403. Epub 2011 Oct 24.
10
Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition.
Cancer Cell. 2011 Jun 14;19(6):701-14. doi: 10.1016/j.ccr.2011.04.017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验